Aprea Therapeutics, Inc. (APRE) — Dilution Risk Analysis
Current Snapshot
Aprea Therapeutics, Inc. (APRE) has a DilutionWatch score of 61/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 61/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
3 shelf registration or ATM offering filings detected in recent history.
Recent filing forms in the source payload: XBRL 1, EFFECT 2, 424B3 2, S-3 1, 8-K 2, 4 2.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-7142-xbrl_warrant |
| EFFECT | 2026-04-29 | 9999999995-26-001389 |
| 424B3 | 2026-04-29 | 0001104659-26-051739 |
| S-3 | 2026-04-22 | 0001104659-26-046900 |
| 8-K | 2026-04-01 | 0001104659-26-038258 |
| 4 | 2026-04-01 | 0001104659-26-038518 |
| 4 | 2026-04-01 | 0001104659-26-038522 |
| 8-K | 2026-03-30 | 0001104659-26-036821 |
| 424B3 | 2026-03-19 | 0001104659-26-032181 |
| EFFECT | 2026-03-19 | 9999999995-26-000871 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 37 months | Source |
| Three-year share count growth | 236.96% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 61/10) Source
- Cash Runway
- 37 months Source
- Share Count Growth (3-Year)
- 236.96% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.